This article was originally published in The Tan Sheet
Kenneth Wright will assume leadership of CDER's Organizational Development & Strategic Planning Team effective Dec. 2, FDA announces Nov. 26. Wright, a 25-year Environmental Protection Agency veteran, is joining the center as it prepares to assume oversight of many biologics currently handled by CBER; the agency also is working on "de-layering" CDER in 2003 as part of its review of management functions. On Nov. 27, FDA announces Steven Niedelman will take over as CDER Assistant Commissioner for Regulatory Affairs effective Dec. 1; Niedelman previously served as Acting Director of the Office of Enforcement...
You may also be interested in...
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.